Refresh

Aarti Pharmalabs Ltd. - Research Center

543748 AARTIPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22

Sales

714.28 777.65

Operating profit

150.55 158.98

Interest

7.85 9.57

Gross profit

147.56 150.65

EPS (Rs)

9.87 10.28
Half yearly  results in details
Sep ' 23 Sep ' 22

Other income

4.86 1.24

Stock adjustment

-25.40 -73.26

Raw material

390.52 494.88

Power and fuel

- -

Employee expenses

61.37 58.33

Excise

- -

Admin and selling expenses

- -

Research and development expenses

- -

Expenses capitalised

- -

Other expenses

137.24 138.72

Provisions made

- -

Depreciation

31.76 26.96

Taxation

26.36 30.50

Net profit / loss

89.44 93.19

Extra ordinary item

- -

Prior year adjustments

- -

Equity capital

45.31 45.31

Equity dividend rate

- -

Agg.of non-prom. shares (Lacs)

- -

Agg.of non promotoholding (%)

- -

OPM (%)

21.08 20.44

GPM (%)

20.52 19.34

NPM (%)

12.44 11.96
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com